Effects of lipid mediators on the synthesis of leukaemia inhibitory factor and interleukin 6 by human bone marrow stromal cells

Cytokine

Volumn 10, Issue 10, 1998, Pages 781-785

  Denizot, Y ^a   Trimoreau, F ^a   Praloran, V ^a  

^a UNIVERSITY OF LIMOGES   (France)

Author keywords

HETE; IL 6; Leukotriene; LIF; Marrow stromal cells; PAF; Prostaglandin

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 15 HYDROXYICOSATETRAENOIC ACID; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; LEUKOTRIENE B4; PROSTAGLANDIN E2; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; BONE MARROW CELL; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FETAL CALF SERUM; HEMATOPOIESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STROMA CELL;

EID: 0032192207     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1998.0360     Document Type: Article

References (34)

1. 1. Dorshkind K (1990) Regulation of hemopoiesis by bone marrow stromal cells and their products. Annu Rev Immunol 8:111-137.
2. 2. Rougier F, Dupuis F, Denizot Y (1996) Human bone marrow fibroblasts - an overview of their characterization, proliferation and inflammatory mediator production. Hematol Cell Ther 38:241-246.
3. 3. Wetzler M, Talpaz M, Lowe DG, Baiocchi G, Gutterman JU, Kurzrock R (1991) Constitutive expression of leukemia inhibitory factor RNA by human bone marrow stromal cells and modulation by IL-1, TNF-α, and TGF-β. Exp Hematol 19:347-351.
4. 4. Lorgeot V, Rougier F, Fixe P, Cornu E, Praloran V, Denizot Y (1997) Spontaneous and inducible production of leukaemia inhibitory factor by human bone marrow stromal cells. Cytokine 9:754-758.
5. 5. Rougier F, Cornu E, Praloran, Denizot Y (1998) IL-6 and IL-8 production by human bone marrow stromal cells. Cytokine 10:93-97.
6. 6. Mori M, Yamaguchi K, Honda S, Nagasaki K, Ueda M, Abe O, Abe K (1991) Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor. Cancer Res 51:6656-6659.
7. 7. Baumann H, Wong GG (1989) Hepatocyte-stimulating factor III shares structural and functional identity with leukemia inhibitory factor. J Immunol 143:1163-1167.
8. 8. Gearing DP, Thut CJ, Vandenbos T, Gimpel SD, Delaney PB, King J, Price V, Cosman D, Beckmann MP (1991) Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer gp130. EMBO J 10:2839-2848.
9. 9. Dupuis F, Desplat V, Praloran V, Denizot Y (1997) Effects of lipidic mediators on the growth of human myeloid and erythroid marrow progenitors. J Lipid Mediators Cell Signalling 16:117-125.
10. 10. Rossi GB, Migliaccio AR, Migliaccio G, Lettieri F, Di Rosa M, Mastroberardino G, Peschle C (1980) In vitro interactions of PGE2 and cAMP with murine and human erythroid precursors. Blood 56:74-79.
11. 4. Biochem Biophys Res Commun 131:579-585.
12. 12. Denizot Y, Dupuis F, Trimoreau F, Verger C, Allegraud A, Praloran V (1996) PAF and haematopoiesis: IX. Platelet-activating factor increases DNA synthesis in human bone marrow cells. J Lipid Mediators Cell Signalling 15:1-4.
13. 13. Rougier F, Dupuis F, Cornu E, Dulery C, Praloran V, Denizot Y (1997) Platelet-activating factor and antagonists modulate DNA synthesis in human bone marrow stromal cell cultures. J Lipid Mediators Cell Signalling 16:147-153.
14. 14. Postoak D, Nystuen L, King L, Ueno M, Beckman BS (1990) 15-lipoxygenase products of arachidonate play a role in proliferation of transformed erythroid cells. Am J Physiol 259:C849-C853.
15. 15. Taetle R, Guittard JP, Mendelsohn JM (1980) Abnormal modulation of granulocyte/macrophage progenitor proliferation by prostaglandin E in chronic myeloproliferative disorders. Exp Hematol 8:1190-1201.
16. 16. Taetle R, Koessler A (1980) Effects of cyclic nucleotides and prostaglandins on normal and abnormal human myeloid progenitor proliferation. Cancer Res 40:1223-1229.
17. 17. Aglietta M, Piacibello W, Gavosto F (1980) Insensitivity of chronic myeloid leukemia cells to inhibition of growth by prostaglandin E. Cancer Res 40:2507-2511.
18. 18. Schafer AI (1982) Deficiency of platelet lipoxygenase activity in myeloproliferative disorders. N Engl J Med 306:381-386.
19. 19. Fixe P, Rougier F, Ostyn E, Gachard N, Faucher JL, Praloran V, Denizot Y (1997) Spontaneous and inducible production of macrophage colony-stimulating factor by human bone marrow stromal cells. Eur Cytokine Netw 8:91-95.
20. 20. Tanabe M, Ochi T, Tomita T, Suzuki R, Sakata T, Shimaoka Y, Nakagawa S, Ono K (1994) Remarkable elevation of interleukin 6 and interleukin 8 levels in the bone marrow serum of patients with rheumatoid arthritis. J Rheumatol 21:830-835.
21. 21. Lorgeot V, Trimoreau F, Gachard N, Praloran V, Denizot Y (1997) Leukemia inhibitory factor (LIF) concentrations in the bone marrow plasma of healthy subjects and patients with hematologic malignancies. Eur Cytokine Netw 8:57-59.
22. 22. Ziboh VA, Miller AM, Wu MC, Yunis AA, Jimenez J, Wong G (1982) Induced release and metabolism of arachidonic acid from myeloid cells by purified colony-stimulating factor. J Cell Physiol 113:67-72.
23. 23. Lindgren JA, Stenke L, Mansour M, Edenius C, Laurén L, Näsman-Glaser B, Ericsson I, Reizenstein P (1993) Formation and effects of leukotrienes and lipoxins in human bone marrow. J Lipid Mediators 6:313-320.
24. 24. Stenke L, Lauren L, Reizenstein P, Lindgren A (1987) Leukotriene production by fresh human bone marrow cells: evidence of altered lipoxygenase activity in chronic myelocytic leukemia. Exp Hematol 15:203-207.
25. 25. Dupuis F, Rougier F, Trimoreau F, Ostyn E, Dulery C, Praloran V, Denizot Y (1997) Production and metabolism of platelet-activating factor by human bone marrow cells. Res Immunol 148:119-126.
26. 26. Escary JL, Perreau J, Duménil D, Ezine S, Brulet P (1993) Leukemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature 363:361-364.
27. 27. Rola-Pleszczynski M, Thivierge M, Gagnon N, Lacasse C, Stankova J (1993) Differential regulation of cytokine and cytokine receptor genes by PAF, LTB4 and PGE2. J Lipid Mediators 6:175-181.
28. 2 enhances interleukin 8 (IL-8) and IL-6 but inhibits GMCSF production by IL-1 stimulated human synovial fibroblasts in vitro. J Rheumatol 23:862-868.
29. 29. Dechanet J, Taupin JL, Chomarat P, Rissoan MC, Moreau JF, Blanchereau J, Miossec P (1994) Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes. Eur J Immunol 24:3222-3228.
30. 30. Braquet P, Pignol B, Maisonnet T, Mencia-Huerta JM (1991) Platelet-activating factor modulates interleukin-6 production by mouse fibroblasts. Int Arch Allergy Appl Immunol 94:165-166.
31. 31. Pignol B, Maisonnet T, Guinot P, Mencia-Huerta JM, Braquet P (1994) Effects of platelet-activating factor on in vitro and in vivo interleukin-6 production. Med Inflamm 3:281-285.
32. 32. Fries KM, Blieden T, Looney RJ, Sempowski GD, Silvera RM, Willis RA, Phipps RP (1994) Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clin Immunol Immunopathol 72:283-292.
33. 33. Denizot Y, Rougier F, Dupuis F, Verger C, Dulery C, Laskar M, Aldigier JC, Praloran V (1996) PAF and haematopoiesis. VIII. Biosynthesis and metabolism of PAF by human bone marrow stromal cells. Exp Hematol 24:1327-1332.
34. 34. Fixe P, Lorgeot V, Le Meur Y, Coupey L, Heymann D, Godard A, Praloran V (1996) Development of enzymo-immunoassays (EIA) for macrophage colony-stimulating factor (M-CSF) and leukemia inhibitory factor (LIF) by using the same capture and signal generating polyclonal antibody. Cytokine 8:586-591.